dc.contributor.author
Röhr, Franziska
dc.contributor.author
Bucholtz, Nina
dc.contributor.author
Toepfer, Sarah
dc.contributor.author
Norman, Kristina
dc.contributor.author
Spira, Dominik
dc.contributor.author
Steinhagen-Thiessen, Elisabeth
dc.contributor.author
Lill, Christina M.
dc.contributor.author
Bertram, Lars
dc.contributor.author
Demuth, Ilja
dc.contributor.author
Buchmann, Nikolaus
dc.contributor.author
Düzel, Sandra
dc.date.accessioned
2020-09-11T10:13:12Z
dc.date.available
2020-09-11T10:13:12Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/28210
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-27960
dc.description.abstract
It has been suggested that an age-related loss of cognitive function might be driven by atherosclerotic effects associated with altered lipid patterns. However, the relationship between Lipoprotein (a) [Lp(a)] and healthy cognitive aging has not yet been sufficiently investigated. For the current analysis we used the cross-sectional data of 1,380 Berlin Aging Study II (BASE-II) participants aged 60 years and older (52.2% women, mean age 68 ± 4 years). We employed the Consortium to Establish a Registry for Alzheimer’s Disease (CERAD)-Plus test battery to establish latent factors representing continuous measures of domain specific cognitive functions. Regression models adjusted for APOE genotypes, lipid parameters and other risk factors for cognitive impairment were applied to assess the association between Lp(a) and performance in specific cognitive domains. Men within the lowest Lp(a)-quintile showed better cognitive performance in the cognitive domain executive functions and processing speed (p = 0.027). No significant results were observed in women. The results of the current analysis of predominantly healthy BASE-II participants point towards an association between low Lp(a) concentrations and better cognitive performance. However, evidence for this relationship resulting from the current analysis and the employment of a differentiated cognitive assessment is rather weak.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Lipoprotein (a)
en
dc.subject
Berlin Aging Study II (BASE-II)
en
dc.subject
healthy cognitive aging
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Relationship between Lipoprotein (a) and cognitive function – Results from the Berlin Aging Study II
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
10636
dcterms.bibliographicCitation.doi
10.1038/s41598-020-66783-3
dcterms.bibliographicCitation.journaltitle
Scientific Reports
dcterms.bibliographicCitation.originalpublishername
Nature Research
dcterms.bibliographicCitation.volume
10
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
32606300
dcterms.isPartOf.eissn
2045-2322